Short Title: Standard vs. Lower Pressure Pneumoperitoneum
Launched by CEDARS-SINAI MEDICAL CENTER · Mar 27, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different levels of air pressure used during laparoscopic surgery affect patients' post-operative pain and the visibility of the surgical area. Laparoscopic surgery is a minimally invasive technique that allows surgeons to perform operations through small cuts in the body, which can lead to quicker recovery times. The trial is specifically looking at female patients aged 18 and older who are scheduled for laparoscopic surgery at Cedars-Sinai Medical Center.
To participate in the trial, patients need to agree to follow all study procedures and provide written consent. However, certain individuals may not be eligible, including those who are pregnant, require urgent surgery, or are already using pain medications like opioids. Participants can expect to be part of a study that aims to improve post-surgery experiences, with careful monitoring throughout the process. Overall, this research could help us understand how to make laparoscopic surgeries even more effective and comfortable for patients.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Provision of signed and dated informed consent form
- • Stated willingness to comply with all study procedures and availability for the duration of the study
- • 18 years of age or older
- • Undergoing laparoscopic surgery at Cedars-Sinai Medical Center with a surgeon in the Minimally Invasive Gynecologic Surgery division.
- Exclusion Criteria:
- • Pregnancy
- • Urgent/non-scheduled surgery
- • Scheduled for planned or possible concomitant non-gynecologic surgery (e.g., urologic or colorectal procedure)
- • Baseline opioid use
- • Allergy or intolerance to bupivacaine (or amide class of anesthetics), oxycodone, acetaminophen, or ibuprofen
- • Planned post-operative admission
About Cedars Sinai Medical Center
Cedars-Sinai Medical Center is a renowned nonprofit academic medical center located in Los Angeles, California, recognized for its commitment to patient care, research, and education. As a leading institution in clinical trials, Cedars-Sinai harnesses innovative approaches to advance medical knowledge and improve treatment outcomes across various specialties. With a multidisciplinary team of experts, state-of-the-art facilities, and a patient-centered approach, Cedars-Sinai actively contributes to the development of novel therapies and interventions, ensuring the highest standards of clinical research while prioritizing patient safety and ethical considerations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
Matthew Siedhoff, MD
Principal Investigator
Cedars-Sinai Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported